Evidence map›Paper›PMID 40627133›Full record

ArticleAbdominal radiology (New York)2026

Deep learning 3D super-resolution radiomics model based on Gd-enhanced MRI for improving preoperative prediction of HCC pathological grading.

Fei Jia, Baolin Wu, Zhuo Wang, Jingqi Jiang, Jinrui Liu, Yang Liu, Yanhu Zhou, Xuelian Zhao, Wenxia Yang, Yuhui Xiong and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fei Jia *Department of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Baolin Wu *Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Zhuo Wang *Department of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Jingqi JiangDepartment of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Jinrui LiuDepartment of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Yang LiuDepartment of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Yanhu ZhouDepartment of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Xuelian ZhaoDepartment of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Wenxia YangDepartment of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Yuhui XiongGE HealthCare MR Research, Beijing, China.
Yanli JiangDepartment of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. 61961048@qq.com.
Jing ZhangDepartment of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. ery_zhangjing@lzu.edu.cn.

Funding

"Cuiying Scientific and Technological Innovation Program" of Lanzhou University Second Hospital CY2021-QN-B09Department of Education of Gansu Province: Innovation Fund Project 2022B-056Gansu Provincial Science and Technology Program Project (Innovation Base and Talent Program) Clinical Medical Research Center Construction 21JR7RA438Lanzhou Science and Technology Bureau Science and Technology Plan Project 2023-2-1
6 · The paper itself

Abstract

purposeThe histological grade of hepatocellular carcinoma (HCC) is an important factor associated with early tumor recurrence and prognosis after surgery. Developing a valuable tool to assess this grade is essential for treatment. This study aimed to evaluate the feasibility and efficacy of a deep learning-based three-dimensional super-resolution (SR) magnetic resonance imaging radiomics model for predicting the pathological grade of HCC.

methodsA total of 197 HCC patients were included and divided into a training cohort (n = 157) and a testing cohort (n = 40). Three-dimensional SR technology based on deep learning was used to obtain SR hepatobiliary phase (HBP) images from normal-resolution (NR) HBP images. High-dimensional quantitative features were extracted from manually segmented volumes of interest in NRHBP and SRHBP images. The gradient boosting, light gradient boosting machine, and support vector machine were used to develop three-class (well-differentiated vs. moderately differentiated vs. poorly differentiated) and binary radiomics (well-differentiated vs. moderately and poorly differentiated) models, and the predictive performance of these models was evaluated using several measures.

resultsAll the three-class models using SRHBP images had higher area under the curve (AUC) values than those using NRHBP images. The binary classification models developed with SRHBP images also outperformed those with NRHBP images in distinguishing moderately and poorly differentiated HCC from well-differentiated HCC (AUC = 0.849, sensitivity = 77.8%, specificity = 76.9%, accuracy = 77.5% vs. AUC = 0.603, sensitivity = 48.1%, specificity = 76.9%, accuracy = 57.5%; p = 0.039). Decision curve analysis revealed the clinical value of the models.

conclusionsDeep learning-based three-dimensional SR technology may improve the performance of radiomics models using HBP images for predicting the preoperative pathological grade of HCC.

Indexed as

Carcinoma, HepatocellularDeep LearningImaging, Three-DimensionalLiver NeoplasmsMagnetic Resonance ImagingAdultAgedContrast MediaFeasibility StudiesFemaleGadoliniumHumansImage Interpretation, Computer-AssistedMaleMiddle AgedNeoplasm GradingContrast MediaGadoliniumDeep learningHepatocellular carcinomaPathological gradeRadiomicsSuper-resolution

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.